Paper17514637
Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases.
Bodingbauer M and 5 others. Br J Surg, 2007. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Papers, record 17514637. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17514637
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Liver Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Prognosis | |
| Prospective Studies | |
| Risk Factors | |
| Survival Analysis | |
| Treatment Outcome |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 18161908 | Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases (Br J Surg 2007; 94: 1133-1138). | https://conductscience.org/library/papers/18161908 |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41216284 | Margins matter: raising the bar for thermal ablation through quantitative imaging validation in COVER-ALL. | Transl Gastroenterol Hepatol | 2025 | https://conductscience.org/library/papers/41216284 | PubMed |
| 37811094 | Colorectal cancer hepatic metastases resection margins outcomes: a single-centre retrospective cohort study. | Ann Med Surg (Lond) | 2023 | https://conductscience.org/library/papers/37811094 | PubMed |
| 36969881 | Prognostic Impact of Surgical Margin Width in Hepatectomy for Colorectal Liver Metastasis. | J Clin Transl Hepatol | 2023 | https://conductscience.org/library/papers/36969881 | PubMed |
| 36922643 | Label-free multiphoton microscopy enables histopathological assessment of colorectal liver metastases and supports automated classification of neoplastic tissue. | Sci Rep | 2023 | https://conductscience.org/library/papers/36922643 | PubMed |
| 34023941 | Relevance of chemotherapy and margin status in colorectal liver metastasis. | Langenbecks Arch Surg | 2021 | https://conductscience.org/library/papers/34023941 | PubMed |
| 32577822 | Outcome quality standards for surgery of colorectal liver metastasis. | Langenbecks Arch Surg | 2020 | https://conductscience.org/library/papers/32577822 | PubMed |
| 31735649 | Histopathological growth patterns and positive margins after resection of colorectal liver metastases. | HPB (Oxford) | 2020 | https://conductscience.org/library/papers/31735649 | PubMed |
| 29098384 | Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy. | Int J Colorectal Dis | 2018 | https://conductscience.org/library/papers/29098384 | PubMed |
| 28884391 | Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases. | J Gastrointest Surg | 2017 | https://conductscience.org/library/papers/28884391 | PubMed |
| 28008341 | Resection margin influences the outcome of patients with bilobar colorectal liver metastases. | World J Hepatol | 2016 | https://conductscience.org/library/papers/28008341 | PubMed |
| 27583880 | Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: A meta-analysis. | Medicine (Baltimore) | 2016 | https://conductscience.org/library/papers/27583880 | PubMed |
| 27384430 | Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases. | J Gastrointest Surg | 2016 | https://conductscience.org/library/papers/27384430 | PubMed |
| 27294032 | Factors affecting surgical margin recurrence after hepatectomy for colorectal liver metastases. | Gland Surg | 2016 | https://conductscience.org/library/papers/27294032 | PubMed |
| 26220046 | Oncological safety of ultrasound-guided laparoscopic liver resection for colorectal metastases: a case-control study. | Updates Surg | 2015 | https://conductscience.org/library/papers/26220046 | PubMed |
| 26198997 | Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection: a systematic review and meta-analysis. | Int J Colorectal Dis | 2015 | https://conductscience.org/library/papers/26198997 | PubMed |
| 26109140 | Oncological outcomes of laparoscopic surgery of liver metastases: a single-centre experience. | Updates Surg | 2015 | https://conductscience.org/library/papers/26109140 | PubMed |
| 25528650 | Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis. | World J Surg Oncol | 2014 | https://conductscience.org/library/papers/25528650 | PubMed |
| 25451734 | Intraoperative surgical margin re-resection for colorectal liver metastasis: is it worth the effort? | J Gastrointest Surg | 2015 | https://conductscience.org/library/papers/25451734 | PubMed |
| 25427420 | Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases. | Surg Endosc | 2015 | https://conductscience.org/library/papers/25427420 | PubMed |
| 25041611 | Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens. | HPB (Oxford) | 2015 | https://conductscience.org/library/papers/25041611 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17514637
GET https://conductscience.org/api/papers/v1/17514637/cited_by?page=2